About Index Trending news
Lists
Pricing
Michael Wiliams

Michael Wiliams

Michael Wiliams

Endologix is a developer and manufacturer of minimally invasive treatments foraortic disorders.

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO debt
$170,000,000
Venture capital
$15,000,000
Employees

Team size

500+
Locations
HQ
Headquarters
$170,000,000 Post-IPO debt
socaltech

Endologix Gets $170M Credit Facility